Mn Services Vermogensbeheer B.V. Repligen Corp Transaction History

Mn Services Vermogensbeheer B.V.

  • $14.3 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 29, 2024
SELL
$170.78 - $208.42 $495,262 - $604,418
-2,900 Reduced 11.93%
21,400 $3.94 Million
Q4 2023

Jan 29, 2024
SELL
$114.17 - $185.35 $102,753 - $166,815
-900 Reduced 3.57%
24,300 $4.37 Million
Q2 2023

Aug 09, 2023
BUY
$138.42 - $180.31 $3.49 Million - $4.54 Million
25,200 New
25,200 $3.57 Million

Others Institutions Holding RGEN

# of Institutions
488
Shares Held
54.2M
Call Options Held
341K
Put Options Held
235K
View Full List

About REPLIGEN CORP

RGEN Quotes by TradingView
  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $8.02B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Mn Services Vermogensbeheer B.V. Portfolio

Follow Mn Services Vermogensbeheer B.V. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mn Services Vermogensbeheer B.V., based on Form 13F filings with the SEC.

News

Stay updated on Mn Services Vermogensbeheer B.V. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email